Timothy L. Chapman,
president of Healthcare
at STERIS Corporation
president of Healthcare
at STERIS Corporation
STERIS Corporation Promotes Timothy L. Chapman
February 06, 2008
by Barbara Kram, Editor
MENTOR, Ohio - STERIS Corporation (NYSE: STE) has announced that Timothy L. Chapman has been promoted to senior vice president and group president, Healthcare. Mr. Chapman joined the Company in January 2006, as senior vice president, Business Strategy. In his new role, Chapman replaces Charles L. Immel, who has decided to pursue other opportunities outside the Company.
Chapman, 45, will report to Walt Rosebrough, president and chief executive officer, and will have responsibility for the Company's Healthcare segment, a leading provider of infection prevention and surgical equipment, consumables and services to customers such as acute care hospitals and outpatient surgical centers. Mr. Chapman will also retain responsibility for the Company's business strategy function.
"We are very fortunate to have a top performer like Tim for such a significant role in the Company," said Walt Rosebrough, president and chief executive officer of STERIS. "Tim has considerable experience in healthcare, not only at STERIS, but across the industry and has a deep understanding of the market and our customers. I am confident that Tim will bring considerable perspective and leadership to his role. Chuck Immel has made a number of contributions to STERIS Corporation over the past seven years and we all wish him the best in his career beyond STERIS."
During his time at STERIS, Mr. Chapman has had responsibility for leading STERIS's strategic planning, business development and supply chain management activities where he has established greater discipline and structure in the Company's processes. Additionally, Mr. Chapman has worked closely with healthcare customers to better understand their needs and form relationships with them to improve performance across a range of activities.
Prior to joining STERIS Corporation, Chapman was a director of McKinsey & Company's Cleveland office and served as a leader in the firm's Healthcare Practice for 15 years, working closely with numerous healthcare institutions on a broad range of organizational, strategic and operational issues. He also founded and led the purchasing and supply chain management practice while at McKinsey.
Mr. Chapman earned a bachelor's degree in Economics from Dartmouth College and a master's degree in Business Administration with distinction from the Amos Tuck School at Dartmouth. He is a board member of the Make-A-Wish Foundation of Greater Ohio and Kentucky, and previously served that organization as a national board member.
About STERIS
The mission of STERIS Corporation is to provide a healthier today and safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. The Company's more than 5,000 dedicated employees around the world work together to supply a broad array of solutions by offering a combination of equipment, consumables and services to healthcare, pharmaceutical, industrial and government customers. The Company is listed on the New York Stock Exchange under the symbol STE. For more information, visit www.steris.com.
Chapman, 45, will report to Walt Rosebrough, president and chief executive officer, and will have responsibility for the Company's Healthcare segment, a leading provider of infection prevention and surgical equipment, consumables and services to customers such as acute care hospitals and outpatient surgical centers. Mr. Chapman will also retain responsibility for the Company's business strategy function.
"We are very fortunate to have a top performer like Tim for such a significant role in the Company," said Walt Rosebrough, president and chief executive officer of STERIS. "Tim has considerable experience in healthcare, not only at STERIS, but across the industry and has a deep understanding of the market and our customers. I am confident that Tim will bring considerable perspective and leadership to his role. Chuck Immel has made a number of contributions to STERIS Corporation over the past seven years and we all wish him the best in his career beyond STERIS."
During his time at STERIS, Mr. Chapman has had responsibility for leading STERIS's strategic planning, business development and supply chain management activities where he has established greater discipline and structure in the Company's processes. Additionally, Mr. Chapman has worked closely with healthcare customers to better understand their needs and form relationships with them to improve performance across a range of activities.
Prior to joining STERIS Corporation, Chapman was a director of McKinsey & Company's Cleveland office and served as a leader in the firm's Healthcare Practice for 15 years, working closely with numerous healthcare institutions on a broad range of organizational, strategic and operational issues. He also founded and led the purchasing and supply chain management practice while at McKinsey.
Mr. Chapman earned a bachelor's degree in Economics from Dartmouth College and a master's degree in Business Administration with distinction from the Amos Tuck School at Dartmouth. He is a board member of the Make-A-Wish Foundation of Greater Ohio and Kentucky, and previously served that organization as a national board member.
About STERIS
The mission of STERIS Corporation is to provide a healthier today and safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. The Company's more than 5,000 dedicated employees around the world work together to supply a broad array of solutions by offering a combination of equipment, consumables and services to healthcare, pharmaceutical, industrial and government customers. The Company is listed on the New York Stock Exchange under the symbol STE. For more information, visit www.steris.com.